Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study

BACKGROUND: The CLARITY and CLARITY Extension studies demonstrated that treatment of relapsing–remitting multiple sclerosis (RRMS) with cladribine tablets (CT) results in significant clinical improvements, compared with placebo. This paper presents the key magnetic resonance imaging (MRI) findings f...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Neurol Disord
Main Authors: Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin
Format: Artigo
Language:Inglês
Published: SAGE Publications 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788142/
https://ncbi.nlm.nih.gov/pubmed/29399054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285617753365
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items